Accu-Tell COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/ Serum/ Plasma)
[Linking template=”default” type=”products” search=”Accu-Tell Rapid Test Cassette” header=”4″ limit=”118″ start=”3″ showCatalogNumber=”true” showSize=”true” showSupplier=”true” showPrice=”true” showDescription=”true” showAdditionalInformation=”true” showImage=”true” showSchemaMarkup=”true” imageWidth=”” imageHeight=””]
For any query Contact Us Below:
Multicenter analysis of two chemiluminescence and three lateral circulation immunoassays for the prognosis of COVID-19 and evaluation of antibody dynamic responses to SARS-CoV-2 in Taiwan
This multicenter, retrospective examine included 346 serum samples from 74 sufferers with coronavirus illness 2019 (COVID-19) and 194 serum samples from non-COVID-19 sufferers to judge the efficiency of 5 anti-severe Accu-Tell COVID-19 IgG acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody exams, i.e., two chemiluminescence immunoassays (CLIAs): Roche Elecsys® Anti-SARS-CoV-2 Test (Roche Test) and Abbott SARS-CoV-2 IgG (Abbott Test), and three lateral circulation immunoassays (LFIAs): Wondfo SARS-CoV-2 Antibody Test (Wondfo Test), ASK COVID-19 IgG/IgM Rapid Test (ASK Test), and Dynamiker 2019-nCoV IgG/IgM Rapid Test (Dynamiker Test).
We discovered excessive diagnostic sensitivities (%, 95% confidence interval [CI]) for the Roche Test (97.4%, 93.4-99.0%), Abbott Test (94.0%, 89.1-96.8%), Wondfo Test (91.4%, 85.8-94.9%), ASK Test (97.4%, 93.4-99.0%), and Dynamiker Test (90.1%, 84.3-94.0%) after > 21 days of symptom onset Accu-Tell COVID-19 IgG. Meanwhile, the diagnostic specificity was 99.0% (95% CI, 96.3-99.7%) for the Roche Test, 97.9% (95% CI, 94.8-99.2%) for the Abbott Test, and 100.0% (95% CI, 98.1-100.0%) for the three LFIAs.
Cross-reactivity was noticed in sera containing anti-cytomegalovirus (CMV) IgG/IgM antibodies and autoantibodies. No distinction was noticed within the time to seroconversion detection of the 5 serological exams COVID-19 Rapid Test. Specimens from sufferers with COVID-19 pneumonia demonstrated a shorter seroconversion time and better chemiluminescent sign than these with out pneumonia Accu-Tell COVID-19 IgG.
Our information advised that understanding the dynamic antibody response after COVID-19 Rapid Test an infection and efficiency traits of various serological take a look at are essential for the suitable interpretation of serological take a look at end result for the prognosis and threat evaluation of affected person with COVID-19 an infection.
Performance analysis of two SARS-CoV-2 IgG/IgM speedy exams (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)
The goal of this examine was to evaluate the analytical performances, sensitivity and specificity, of two speedy exams (Covid- Presto® take a look at speedy Covid-19 IgG/IgM and NG-Test® IgM-IgG COVID-19) and one automated immunoassay (Abbott SARS-CoV-2 IgG) for detecting anti- SARS-CoV-2 antibodies Accu-Tell COVID-19 IgG.
This examine was carried out with: (i) a optimistic panel constituted of 88 SARS-CoV-2 specimens collected from sufferers with a optimistic SARS-CoV-2 RT-PCR, and (ii) a adverse panel of 120 serum samples, all collected earlier than November 2019, together with 64 samples with a cross-reactivity panel COVID-19 Rapid Test. Sensitivity of Covid-Presto® take a look at for IgM and IgG was 78.4% and 92.0%, respectively.
Sensitivity of NG-Test® for IgM and IgG was 96.6% and 94.9%, respectively. Sensitivity of Abbott IgG assay was 96.5% displaying a superb settlement with the 2 speedy exams (κ = 0.947 and κ = 0.936 for NGTest ® and Covid-Presto® take a look at, respectively).
An wonderful settlement was additionally noticed between the 2 speedy exams (κ = 0.937) Accu-Tell COVID-19 IgG. Specificity for IgM was 100% and 86.5% for Covid-Presto® take a look at and NG-Test®, respectively COVID-19 Rapid Test. Specificity for IgG was 92.0%, 94.9% and 96.5% for Covid-Presto®, NGTest ®, and Abbott, respectively.
Most of the false optimistic outcomes noticed with NG-Test® resulted from samples containing malarial antibodies. In conclusion, performances of those 2 speedy exams are excellent and corresponding to these obtained with automated immunoassay Accu-Tell COVID-19 IgG, aside from IgM specificity with the NG-Test COVID-19 Rapid Test. Thus, remoted IgM must be cautiously interpreted as a result of attainable false-positive reactions with this take a look at.
Finally, earlier than their massive use, the speedy exams should be reliably evaluated with satisfactory and enormous panel together with early seroconversion and attainable cross-reactive samples COVID-19 Rapid Test.
Community seroprevalence of COVID-19 in possible and attainable circumstances at main well being care centres in Spain
Background: There is a shortage of details about sufferers with delicate or average signs in the course of the coronavirus illness 2019 (COVID-19). This is particularly true for many who attended and have been adopted up at main care settings.
Objectives: We goal to measure the seroprevalence of antibodies in opposition to SARS-CoV-2 an infection in a neighborhood pattern of attainable circumstances and amongst possible circumstances adopted in main care Accu-Tell COVID-19 IgG.
Methods: We chosen a random pattern of 600 people stratified by age teams from a complete inhabitants of 19 899 people from a neighborhood space in Barcelona COVID-19 Rapid Test. We additionally invited all of the sufferers that had been adopted by General Practitioners (GPs). For each populations, we used COVID-19 speedy lateral circulation immunoassays, which qualitatively assess the presence of patient-generated Immunoglobulins G (IgG) and Immunoglobulin M (IgM).
Results: Three hundred and eleven asymptomatic people from the randomly chosen pattern participated within the examine.
The imply age was 43.7 years [standard deviation (SD) = 21.79] and 55% have been ladies. Seventeen people have been seropositive for IgM and/or IgG, leading to an total prevalence of 5.47% (95% confidence interval = 3.44-8.58). Six hundred and thirty-four symptomatic sufferers have been adopted up by GPs COVID-19 Rapid Test. The imply age was 46.97 years (SD = 20.05) and 57.73% have been ladies. Of these, 244 sufferers (38.49%) have been seropositive Accu-Tell COVID-19 IgG. Results of the multivariate logistic regression evaluation confirmed that the percentages ratio for a optimistic take a look at was considerably elevated in sufferers who had fever, ageusia and make contact with with a affected person identified with COVID-19 Rapid Test.
Conclusions: The seroprevalence of antibodies in opposition to SARS-CoV-2 amongst attainable circumstances was decrease than anticipated. Approximately, 40% of the symptomatic sufferers adopted up by GPs in the course of the peak months of the pandemic have been optimistic.